chrisvoncsefalvay/vaers-outcomes huggingface dataset:
red, itchy injection site on upper arm; red, itchy injection site on upper arm; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (red, itchy injection site on upper arm), VACCINATION SITE PAIN (sore arm) and VACCINATION SITE ERYTHEMA (red, itchy injection site on upper arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported historical condition). Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (red, itchy injection site on upper arm) and VACCINATION SITE ERYTHEMA (red, itchy injection site on upper arm). At the time of the report, VACCINATION SITE PRURITUS (red, itchy injection site on upper arm), VACCINATION SITE PAIN (sore arm) and VACCINATION SITE ERYTHEMA (red, itchy injection site on upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Pt received a Gardasil injection before her pregnancy results came back from the lab. The lab results showed she was pregnant.
It started out with vomiting and fever and then really bad stomach pains. Stomach pains after anything I ate or drank. That happened for a couple of days. Then I had blood in my stool and it was like diarrhea. So I went to the ER on 02/09/2021 and they gave me a CAT scan and said there might have been some kind of colitis. Referred me to a specialist. Right after I went home and two days later I went back to the ER with even worse pain. Had blood in my vomit and was kept there for a couple of hours. They again referred me to another gastro appointment. I wasn't able to get into a gastro appointment until 02/26/2021 I believe. When I saw the specialist they said that my symptoms had to do with Colitis. Symptoms worsened and I was admitted again. Became to weak and couldn't walk. I lost like 15lbs. Sched for 03/08/2021 was diagnosed with ulcerative colitis. I was point on medication and put on medical leave for three weeks. I started mesalamine treatment. That didnt work so now im on a biological treatment for every 8 weeks or until further notice.  REMICADE is what I was prescribed. My iron levels had dropped and I had to get two iron treatments through I.V. as well. Seen hematologist
Fever; Hives like blister on wrist and on the back neck; Rash similar to hives on hand and back; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient has not had any allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 08Apr2021 at 14:00, two hours after vaccination, the patient experienced rash similar to hives on hand and back. On 09Apr2021, the patient experienced fever and hives like blister on wrist and on the back neck. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events rash similar to hives on hand and back, fever and hives like blister on wrist and on the back neck was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Per Message: "Hi. I'm reaching out to ask if there were any concerns to headaches post vax. I got the shot on Sun, Mon I laid it bed from achiness, and am now feeling better. Although I'm still experiencing persistent headaches that I continue to take ibuprofen for. I'm going to monitor them but wanted to at least highlight this as a symptom. Thanks!"
Rash from center of chest radiating to left axilla area. Pt states rash oozing and bleeding in axilla area. Chest tightness and nausea. MD prescribed Medrol dosepak, Valtrex, and hydrocodone/APAP and Zyrtec.
maculopapular rash on truncal >100 lesions, no vesicles, seen by me on 4/20/2008, no arm or legs lesions, no other symptoms or signs of illness
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    Concomitant medication was not provided. 196 patients received 0.25mL of Moderna COVID-19 Vaccine, Bivalent. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live follow-up received and added age group.
Patient came to the vaccination center to get her first dose of the Pfizer primary series. The nurse gave her a Pfizer bivalent booster dose in error.  The patient was informed of the error and advised, per CDC guidelines, that she did not need to repeat her first dose of the primary series. The patient was informed that she should return to the vaccination center after 21 days to receive her second dose of the Pfizer primary series vaccine, and then two months after that she would be eligible to receive a second dose of the Pfizer bivalent booster vaccine.
Fever began the first evening and climbed to 104.5 (taken with forehead scanner)  by the next day even with having taken Tylenol.
Patient had seizure for 30 min  after 2 days  of having the vaccine.
Expired vaccine used; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 01-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the expiration date of suspect product was on 25 Sep 2021. No concomitant medications were reported. No treatment information was provided.
Achy; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy) and HEADACHE (Headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045121A, 003A21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Achy) and HEADACHE (Headaches). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (Achy) and HEADACHE (Headaches) outcome was unknown.            No Concomitant medication was reported.
Rash, ErythemaMultiform, UrticariaPruritus, moderate fatigue Narrative:
Headache, arm swelling at the injection site, swelling under armpit, all over severe body aches, painful joints, fever, sensitive painful skin, nausea, diarrhea, stomachache, sensitive painful lower back and spine. Taking  Tylenol every 4-6 hours.
HE HAD SWEATING , FELT LIGHTHEADED,  DESCRIBED THAT HE HAD NOT EATEN TODAY
BP 224/99 P99, patient c/o CP, SOB, and feeling hot, nausea, blurred vision.  Started to sweat, MD alerted, patient send out to ED at 1415 via amb.
Had anthrax vaccine #1 on 10/21/2011. Within 10 min after injection had mild headache 3-4/10, whole body tingling and shaky hands. Next morning headache intensified to 8/10. Headache persisted at thigh level with temporary relief only with MOTRIN 800mg until November 12 when headache resolved. Beginning on Nov 17, has had recurring h/a lasting up to I week/episode with intensity about 6/10 to about 4/10 with MOTRIN. Has not gone more that five consecutive days without a headache recurrence since but over time the intensity seems to be decreasing with typical 4/10 decreasing to 2/10 with MOTRIN. H/A is frontal, bilateral and steady dull ache. Occ nausea no V with more severe h/a episodes. No hearing, visual, or motor changes, no balance problems. No other symptoms identified. Neuro exam normal.
Warm, red, Swollen 3" erythemia 2 inches induration on left upper arm.
Pt received covid-19 vaccine 1st dose 5/15/2021, complained 25 minutes after vaccination of "foreign body in throat" No edema or vomitting. Pt received 2 dose 06/05/2021@ 9.26am; ;complained 45 minutes later of same throat disconfort & near fainting .  Attended ER on 6/5/2021 + hoarness  leg weakness for 5 min paleness .
Client did not experience any adverse reactions. The client had a second varicella administered less than the minimum time allowed because the provider was unaware that the client had received an initial dose 3 weeks prior. The initial dose administered back on March 29, 2023 was not reflective in the client's registry when checked by the provider. The system flagged for a Hepatitis A and a Varicella vaccine on April 18, 2023 when the client presented.  It was not until the client's follow-up visit on 5/16/23 the provider was made aware of a previous varicella given back in March 2023 at another health center.  The parent was made aware that the two systems somehow did not communicate this information.
Tinnitus, brain fog, blurred vision/double vision, ear pain, ear congestion, fatigue, fever, body aches
soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003d21a and 004m20a) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE PAIN. At the time of the report, VACCINATION SITE PAIN outcome was unknown.            No concomitant medication reported.  No treatment medication reported.   Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-232158.
Patient had a  red rash about an inch and a half below the site of injection.It was about 2x2 inches and it was sensitive to the touch.
Injection site pain; severe muscle pain; joint pain; fever; chills; nausea; feeling unwell; headache; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EL3247) via an unspecified route of administration in the right arm on 22Mar2021 at 11:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EL3247) via an unspecified route of administration on 02Mar2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included ibuprofen (ADVIL), vitamin D (MANUFACTURER UNKNOWN), vitamin B (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for unknown indication. Since the vaccination, patient had not been tested for COVID-19. On 22Mar2021 at 18:00, the patient had experienced injection site pain, severe muscle pain, joint pain, fever, chills, nausea, feeling unwell, headache and fatigue. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events injection site pain, severe muscle pain, joint pain, fever, chills, nausea, feeling unwell, headache and fatigue was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.
This case was reported by a physician via call center representative and described the occurrence of fever in a 63-year-old female patient who received SHINGRIX for prophylaxis. On 15th June 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 21st August 2018, 67 days after receiving SHINGRIX, the patient experienced fever, headache and pain. On an unknown date, the outcome of the fever, headache and pain were unknown. It was unknown if the reporter considered the fever, headache and pain to be related to SHINGRIX. Additional details were provided as follows: The reporting physician was the patient. The patient received SHINGRIX on left deltoid. The patient had fever of 102 degree C. This case has been linked with US2018151863, reported by the same reporter.
Had tenderness in his left arm where the injection was given since it was administered/tiny pain occasionally when moving his arms; Initial information received on 28-Nov-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves a 75 years old male patient who had tenderness in his left arm where the injection was given since it was administered/tiny pain occasionally when moving his arms after receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's past medical history included Had vaccine before and experienced soreness for a few days (Pain in extremity). The patient's past medical treatment(s), vaccination(s) and family history were not provided.   On 16-Nov-2022, the patient received 0.7ml dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (strength, formulation was unknown, lot UJ935AA and expiry date: 30-Jun-2023) via intramuscular route in the left arm for Immunization.  On 16-Nov-2022 the patient developed a non-serious event of had tenderness in his left arm where the injection was given since it was administered/tiny pain occasionally when moving his arms (vaccination site pain) (Latency: same day) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT) was not applicable.  Corrective treatment:  The pharmacist who administered the FLUZONE HD QIV recommended that the patient take two IBUPROFEN (IBUPROFEN) as needed throughout the day for Vaccination site pain.  Outcome: Not recovered
A tiny bruise at the injection site after her first 2 shots; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE BRUISING (A tiny bruise at the injection site after her first 2 shots) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Concurrent medical conditions included Cancer (Patient is recovering from cancer.).   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE BRUISING (A tiny bruise at the injection site after her first 2 shots). At the time of the report, VACCINATION SITE BRUISING (A tiny bruise at the injection site after her first 2 shots) outcome was unknown.            No concomitant medication was reported.  Patient did not take any medications to help with the adverse event.   This case was linked to MOD-2022-651643 (Patient Link).
"Patient with a PMH of HTN, Afib RVR (on Eliquis), nonischemic CMO, HFrEF (EF 25%), HLD, HLD, Fe deficiency anemia, Pulmonary HTN, rectus sheath hematoma presented to ED  with LUE edema and pain that started a couple of hours after second dose of COVID vaccine adminstration. Patient had received COVID vaccine shortly after noon day prior to admit on RUE. She reports that she had been experiencing some nausea as well.   She was admitted to the hospital for overnight observation secondary to transient alteration of awareness after she presented to the ED for arm swelling where experienced a syncopal episode lasting approximately 1 minute. She was monitored on cardiac tele which showed Afib with appropriate rate control overnight. For her left upper extremity swelling an U/S was done which was negative for thrombus, only a hematoma. Her arm pain was controlled and supportive with a compress. Patient had no further syncope, Afib rate controlled, and hemodynamically stable. Discharged home 2/24/21.
8/29/06 stated swelling behind right ear and right cheek area 3 days after MMR was given. She stated it got worse, no fever V/S stable. 8/29/06 was seen by Dr. Diagnosis possible parotitis. Pt instructed to apply warm compresses, NSAIDS as needed.
I believe we vaccinated an individual after the beyond use date of the vaccine.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (I believe we vaccinated an individual after the beyond use date of the vaccine.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (I believe we vaccinated an individual after the beyond use date of the vaccine.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (I believe we vaccinated an individual after the beyond use date of the vaccine.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the reporter  No Treatment Information were provided by the reporter
Pt received ZOSTAVAX in 2013. She had itching that comes and goes on back "above flank". She may have had shingles before getting ZOSTAVAX in 2013. She is going to see new dr to see if itching is shingles. Pt gave permission for manuf to call for more details.
Moderna COVID 19 Vaccine EUA .  VERY TIRED/ some weakness, no appetite
BREAKOUT IN OOZING SENSITIVE RASH ON FACE, SWELLING IN LEFT ARM AND LYMPH NODES, INCREASE HEART RATE, SWELLING OF LIPS AND PAIN IN LEFT ARM.
Covid19 breakthrough.  1st Vaccine received on 01/08/2021.  75 y/o PMHx of HTN, DM, Hypothyroid, Diverticulitis, GERD presents to ED with c/o 2 day history of Chest pressure, orthopnea, palpitations, HA and dizziness.  Pt states initially tested positive for Covid19 at MD office on 01/07/2022 and has also had Cough and SOB since.  CXR-no infiltrates or effusions.  Room air sat 100%, Afebrile.
The Vaccine was diluted with 1.4 ml instead of 1.8ml. Patient was called by provider and explained to call with any adverse reactions .
This spontaneous report was received from a health professional referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 07-JUN-2018, the patient was vaccinated with the first dose of VAQTA intramuscularly (dosage schedule, anatomical location, lot number and expiration date were not reported), indicated for prophylaxis. Then on 27-AUG-2018, the patient received the second dose (inappropriate schedule of product administration).
Numb (pins and needles) feeling in part of my left hand. My ring finger and pinkie finger in the left hand had that numb feeling for a few hours. It eventually wore off.
complains  of itching all  over his body he has  caused bruises on his arms He got flu shot three days ago.Hesays the  itching strted soon after receiving the shot.
Pt received pneumovax on 3/8/00 and developed localized redness above the elbow up to the shoulders with minimal warmth, no itching.
1st day: hot flashes 2nd day: low-grade headache, stiff neck, lightheadedness with the feeling of passing out accompanied by lethargy